ClinicalConnection.com New Clinical Trials

Fibromyalgia or Chronic Pain - Maitland FL

4/30/2026

Fibromyalgia - Multiple Locations in the US"/>
Living with fibromyalgia or chronic pain? Consider the FORWARD research study

If you’re living with fibromyalgia or chronic pain, you know how it affects many aspects of your life and can make even daily activities difficult. Your pain may be invisible, but you are not. You could potentially help advance fibromyalgia treatment options by participating in the FORWARD study.

What is the FORWARD Study?

The FORWARD study is a clinical research study for adults with fibromyalgia or suspected fibromyalgia. The goal of the FORWARD study is to look at how an investigational medication AXS-14, also known as esreboxetine, may help fibromyalgia pain and other symptoms in adults. AXS-14 is an investigational medication for fibromyalgia. This means it has not yet been approved by the FDA for use in fibromyalgia.

Who Can Participate?

The FORWARD study is looking for people who*:

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Houston TX

4/30/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Sacramento CA

4/30/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - High Point NC

4/30/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Brooklyn NY

4/30/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Type 2 Diabetes - Tempe AZ

4/29/2026

AMR Clinical is conducting a clinical research study for adults 18+ with Type 2 Diabetes who are overweight or obese. This research study is designed to evaluate different strategies for the management of Type 2 Diabetes, including lifestyle factors, medication effectiveness, and overall health outcomes. Information collected during the study may contribute to a better understanding of Type 2 Diabetes.

High Blood Pressure (Hypertension) - Cincinnati OH

4/29/2026

Hypertension & Heart Disease Study

Adults 18+with high blood pressure and heart disease or increased cardiovascular risk may qualify for a clinical research study evaluating an investigational treatment. Compensation up to $1,200 may be available.

High Blood Pressure (Hypertension) - Valparaiso IN

4/29/2026

Heart Health - At Home Study

4/28/2026

Heart Health - At Home Study"/>

Join a screening study with NO in-person visits

Support heart health research! Enroll in a screening study to see if you’re a candidate for future research and earn compensation for your participation.

Please enter Site Code 353 when requested.

Urticaria At Home - Los Angeles CA

4/27/2026

Urticaria At-Home Research Opportunity

At Sanguine, we are accelerating medicine with the help of volunteers like you. You can contribute to the development of new treatments and help advance Urticaria research with a 35-minute blood donation

Donating is fast, easy, and you will receive up to $100 for your time without leaving home.

You may qualify to participate if:

Subjects who are diagnosed with Urticaria.
Subjects who are currently taking Remibrutinib.

About Sanguine
Sanguine is a leading provider of at-home clinical research services empowering patients to participate in research studies from the comfort of their homes using smart technology and a mobile health staff. For more information, CLICK HERE .

Sickle Cell Disease (SCD) At Home - Fort Worth TX

4/27/2026

Sickle Cell Disease (SCD) At-Home Research Opportunity

At Sanguine, we are accelerating medicine with the help of volunteers like you. You can contribute to the development of new treatments and help advance Sickle Cell Disease (SCD) research with a 125-minute blood donation

Donating is fast, easy, and you will receive up to $100 for your time without leaving home.

You may qualify to participate if:

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home - Dallas TX

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home - Hollywood FL

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home - Wyncote PA

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home - Boston MA

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home - Richmond CA

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home - Los Angeles CA

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Sickle Cell Disease (SCD) At Home Research Opportunity

4/27/2026

Subjects who are diagnosed with Sickle Cell Disease
Subjects ages 28-45

Lupus - Orlando FL

4/27/2026

The Ntrust-1 study
The Ntrust-1 study is part of a broad effort of the global research community to develop more treatment options for people living with lupus nephritis (LN) and primary membranous nephropathy (pMN).

Although current treatments can help manage symptoms, LN and pMN can cause damage to vital organs, including the kidney. More clinical studies are needed to find treatments that target the root of LN and pMN, which could potentially slow or stop its damaging effects. Do you want to help advance LN and pMN medical research? Consider enrolling in the Ntrust-1 study.

What is Ntrust-1 study?
The Ntrust-1 study is a clinical research study evaluating an investigational cell therapy, called NKX019, in adults living with lupus nephritis and primary membranous nephropathy.

What is NKX019?
NKX019 is an investigational cell therapy being studied for lupus nephritis (LN) and primary membranous nephropathy(pMN). It is designed to target and eliminate the cells that may trigger harmful antibodies, which attack the body’s own tissues in these conditions. Academic studies of a small number of autoimmune patients treated with other cell therapy products have indicated that if these cells can be eliminated, the harmful antibodies that attack the body’s own tissues in LN and pMN may also be eliminated. This could potentially slow or stop progression of the disease.

What is the purpose of this study?
As many as half of all adults living with lupus have kidney disease.1 LN can worsen over time and may lead to kidney failure.² pMN is another autoimmune kidney disease that can also lead to progressive kidney damage. Studies like this are designed to assess the safety and activity of a new investigational therapy for both conditions.

The purpose of the Ntrust-1 study is to:

Determine if NKX019 is safe to use and how well it is tolerated
Determine if NKX019 can improve kidney function
See if other medications like steroids can be stopped because LN or pMN is controlled
See how the body processes NKX019 by measuring the NKX019 levels in the blood

Who can join this study? You may be eligible to participate in this study if you:

Are 18 to 70 years old
Have been diagnosed with lupus nephritis or primary membranous nephropathy
Have previously received at least 2 therapies for kidney issues
Do NOT currently require renal (kidney) dialysis

You will also need to meet additional requirements. The study team will review these with you.

Compensation If you are eligible and choose to participate, you will receive NKX019 and health assessments from a team with expertise in caring for people living with LN or pMN. Costs for travel, lodging, childcare, and meals will be covered when you and your care partner go to the study clinic. Compensation for study participants and your care partner may also be available.

Sources:

https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
https://www.kidney.org/kidney-topics/lupus-nephritis

High Blood Pressure (Hypertension) - Suffolk VA

4/23/2026

Heart Health Screening - At Home Study

4/23/2026

Heart Health - At Home Study"/>

Heart and Health Research Screening Study

Are you 22 or older with no history of high blood pressure?

This study is conducted virtually from the comfort of your home

Join a sponsored screening study and get compensated for your time

Please enter Site Code 353 when requested.

Post-Traumatic Stress Disorder (PTSD) - Maitland FL (Metro Orlando)

4/21/2026

Click image to enlarge

Living with PTSD can be challenging — especially if you’ve already tried treatment options. A clinical research study is now enrolling adults 18+ with a confirmed PTSD diagnosis (6+ months). Qualified participants may receive compensation for time and travel, along with study-related care at no cost. Learn more and check eligibility today.

Gout and Hyperuricemia - Marietta GA (Metro Atlanta)

4/21/2026

"Gout is more than just temporary pain; it is caused by a buildup of uric acid crystals in the joints. This study evaluates a 'Treat-to-Target' management plan designed to lower uric acid levels and prevent future attacks. We are looking for individuals who experience recurring gout flares to help us assess the effectiveness of long-term preventative care in achieving a flare-free life."

Metabolic-Associated Steatohepatitis (MASH) - Houston TX

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - Multiple Locations in the US"/>

Struggling with MASH? A clinical trial might help.

Be part of research that may change how fatty liver disease is treated. See if you qualify.

Living with fatty liver disease can be stressful. A clinical trial may offer a new path forward.

Your participation could help your liver health — and help others struggling with fatty liver disease.

Take an active step for your health. See if this fatty liver disease clinical trial is right for you.

Metabolic-Associated Steatohepatitis (MASH) - Ogden UT

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - Yonkers NY

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - New Iberia LA

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - Saint Petersburg FL

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - Fort Lauderdale FL

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - Delray Beach FL

4/20/2026

Metabolic-Associated Steatohepatitis (MASH) - Multiple Locations in the US

4/20/2026

Depression with Excessive Daytime Sleepiness - New York NY

4/17/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Does your depression make it hard to stay awake during the day even after getting enough sleep at night? Consider the CLARITY MDD with EDS research study

If your depression makes it hard to stay awake during the day, even if you get a decent amount of sleep at night, you may be experiencing major depressive disorder with excessive daytime sleepiness. You could potentially help advance research for an investigational medicine for adults with depression with excessive daytime sleepiness symptoms by participating in the CLARITY study.

What is the CLARITY Study?

The CLARITY study is a clinical research study for adults ages 18-65 experiencing an episode of depression along with excessive daytime sleepiness symptoms. The goal of the CLARITY study is to see if the investigational medicine (solriamfetol) is safe and effective in adults with major depressive disorder (MDD) with excessive daytime sleepiness (EDS). Solriamfetol is approved by the FDA for adults who have excessive daytime sleepiness due to obstructive sleep apnea (OSA) and narcolepsy, which are sleep-related disorders. Solriamfetol is an investigational treatment for MDD with EDS, meaning it has not yet been approved by any health authority for the treatment of MDD with EDS.

Study participation will last up to 39 weeks and includes up to 22 in-clinic visits and up to 15 remote visits. Compensation for time and travel may be available. People who participate in the study will receive study-related care at no cost and you don’t need to have health insurance to participate. Each participant’s MDD and overall health will be looked after by a study physician and staff.

Who Can Participate?

The CLARITY study is looking for adults who*:

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Shift Work Sleep Disorder - Anaheim CA

4/17/2026

Shift Work Sleep Disorder - Multiple Locations in the US"/>

Recruiting Participants for the SUSTAIN Shift Work Disorder Research Study

Are you living with shift work disorder (SWD)? Are you feeling excessive sleepiness while working the overnights? Do you have trouble falling asleep after your night shift?

What is the SUSTAIN shift work disorder research study?

The SUSTAIN study is a clinical research study currently being conducted at select centers in the US. The study is for people aged 18 to 65 who are living with excessive sleepiness associated with the shift work schedule*. The SUSTAIN study is evaluating an oral investigational medication (solriamfetol) in adults with Shift Work Disorder (SWD). Solriamfetol is approved by the FDA for people who have excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea (OSA), which are other sleep-related disorders. Solriamfetol is an investigational treatment for SWD, meaning it has not yet been approved by any health authority for the treatment of SWD.

*Other criteria also apply.

What is shift work disorder?

Shift work disorder is characterized by excessive sleepiness, insomnia, and impaired daytime functioning resulting from a mismatch between the body’s internal clock and the required work schedule, primarily affecting people with non-standard work shifts, such as overnights. According to the National Health Interview Survey in 2010, nearly one third of Americans work an alternate shift outside a 7AM to 6PM workday, and of these more than 9.5 million work overnight or rotating shifts¹.

Who Can Participate?

People who are aged 18 to 65 in the U.S. who have experienced symptoms of shift work disorder over the last 3 months may be eligible. Other criteria also apply.

Why Participate?

If you’re living with shift work disorder, The SUSTAIN study may be right for you. If you are eligible to participate:

You may receive the investigational medication.
You may receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatments for people with shift work disorder*.

*Solriamfetol is an investigational oral medication being studied for shift work disorder.

References

[1] T. Alterman, S. E. Luckhaupt, J. M. Dahlhamer, B. W. Ward, and G. M. Calvert, “Prevalence rates of work organization characteristics among workers in the U.S.: data from the 2010 National Health Interview Survey,” Am. J. Ind. Med., vol. 56, no. 6, pp. 647–659, Jun. 2013, doi: 10.1002/ajim.22108.

Obesity or Overweight - Knoxville TN

4/15/2026

AMR Clinical Knoxville is conducting a clinical research study for individuals 18 to 79 who are currently using Wegovy or Zepbound weekly for weight management.

Depression with Excessive Daytime Sleepiness - Oceanside CA

4/15/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Fibromyalgia or Chronic Pain - Phoenix AZ

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Roslindale MA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Austin TX

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Cromwell CT

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Jacksonville FL

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Memphis TN

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Santa Ana CA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Las Vegas NV

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Tampa FL

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Orlando FL

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Lakeland FL

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Winter Park FL

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Buffalo NY

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Norcross GA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Tulsa OK

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Prosper TX

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Redlands CA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Duncansville PA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Dallas TX

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Charleston SC

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Atlanta GA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Prairieville LA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Watertown MA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Marietta GA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Little Rock AR

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Louisville KY

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Leawood KS

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Chesterfield MO

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Springfield MO

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Austin TX

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Anaheim CA

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Chicago IL

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Knoxville TN

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Overland Park KS

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Fibromyalgia or Chronic Pain - Multiple Locations in the US

4/14/2026

Are at least 18 years of age
Have fibromyalgia or experience the symptoms of fibromyalgia (muscle, joint, and bone pain, brain fog, trouble sleeping, etc.)
Do not have any other conditions that cause pain besides fibromyalgia
Are interested in participating in the clinical study

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medication.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new medications for fibromyalgia.

*AXS-14 is an investigational medication for fibromyalgia

Depression with Excessive Daytime Sleepiness - Chicago IL

4/13/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Volunteers for Injection Device Study - Gilbert AZ (Metro Phoenix)

4/13/2026

Click image to enlarge

This study looks to identify design strengths, improvements, and use errors regarding the use of an injection device. Participants will walk through using an injection device on a pad that simulates skin (you will not inject yourself or anyone else), then answer some questions about your experience in a debrief session.

High Blood Pressure - Sun City West AZ

4/9/2026

This trial is looking for individuals who are not quite controlled with their current usage of multiple blood pressure medications. Individuals who take 2 or more blood pressure medications, with at least one of those being a diuretic (water pill) and who also have risk factors for cardiovascular disease or who have established cardiovascular disease, may qualify for a trial aiming to help better control your blood pressure through an injection every 6 months.

Depression with Excessive Daytime Sleepiness - Cherry Hill NJ

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Jacksonville FL

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Edmond OK

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Brooklyn NY

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Walnut Creek CA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Memphis TN

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Redlands CA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Toms River NJ

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Cincinnati OH

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - San Diego CA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Staten Island NY

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Portland OR

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Miami FL

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Bronx NY

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Springfield MA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Chino CA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Dallas TX

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Norcross GA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Snellville GA

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Houston TX

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Pikesville MD

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US

4/9/2026

Depression with Excessive Daytime Sleepiness - Multiple Locations in the US"/>

Are ages 18-65
Are currently experiencing an episode of depression that has lasted at least 4 weeks
Sleep, on average, at least 6 hours per night but have a hard time staying awake during the day and feel excessively sleepy during the day
Don’t have any other sleep disorders, like narcolepsy or obstructive sleep apnea (OSA)

*Additional eligibility criteria apply

Why Participate?

If you are eligible to participate:

You may receive the investigational medicine.
You may also receive study-related care and study evaluations at no cost.
You may also receive compensation for your time and travel.
You may have the opportunity to help advance potential new treatment options for people with depression with excessive daytimesleepiness*.

* Solriamfetol is an investigational medicine being studied in major depressive disorder with excessive daytime sleepiness

Opioid Use Disorder - Philadelphia PA

4/7/2026

Opioid Use Disorder - Multiple Locations in the US"/>
Study for Opioid Use Disorder Now Enrolling

Clinical research may help expand future options for opioid use disorder. A local study is enrolling adults who are taking buprenorphine. Those who qualify will receive:

✅ Study-related care at no cost
✅ Support from research doctors and their study teams
✅ Possible reimbursement for travel + expenses

Opioid Use Disorder - San Francisco CA

4/7/2026

Opioid Use Disorder - West Palm Beach FL

4/7/2026

Opioid Use Disorder - Lakeland FL

4/7/2026

Opioid Use Disorder - Boston MA

4/7/2026